CIN: among no previous SGLT2Is users 64/208 and previous SGLT2Is users 14/104. SGLT2 inhibitors significantly reduced the risk of CIN aOR 0.41; 95% CI 0.142–0.966, p = 0.004. This evidence concerns the gene SLC5A2 and cervical squamous intraepithelial neoplasia.